{"items": "69", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Dave  ( NASDAQ:DAVE ) , ARKO  ( NASDAQ:ARKO ) ", "url": "https://www.benzinga.com/24/12/42740288/sangamo-therapeutics-dave-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session", "time_published": "20241231T134722", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Tuesday. Shares of Sangamo Therapeutics, Inc. SGMO fell sharply in today's pre-market trading as the company announced its collaboration and license agreement with Pfizer on giroctocogene ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/31/movers-image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.114438, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LAES", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.650276", "ticker_sentiment_label": "Bearish"}, {"ticker": "RR", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.400378", "ticker_sentiment_label": "Bearish"}, {"ticker": "SGMO", "relevance_score": "0.491878", "ticker_sentiment_score": "0.348177", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAVE", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.381637", "ticker_sentiment_label": "Bearish"}, {"ticker": "DSGN", "relevance_score": "0.340915", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARKO", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.582437", "ticker_sentiment_label": "Bearish"}, {"ticker": "PFE", "relevance_score": "0.174587", "ticker_sentiment_score": "0.139374", "ticker_sentiment_label": "Neutral"}, {"ticker": "STVN", "relevance_score": "0.340915", "ticker_sentiment_score": "-0.582437", "ticker_sentiment_label": "Bearish"}]}, {"title": "Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Alset  ( NASDAQ:AEI ) , Ambow Education Holding  ( AMEX:AMBO ) ", "url": "https://www.benzinga.com/24/12/42737792/why-cemtrex-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket", "time_published": "20241231T103326", "authors": ["Avi Kapoor"], "summary": "Shares of Cemtrex, Inc. CETX rose sharply in today's pre-market trading after the company posted stronger-than-expected sales for the fourth quarter, reporting quarterly sales of $18.10 million which beat the analyst consensus estimate of $16.39 million.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/31/movers-image.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.118605, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RR", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.238888", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WATT", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.226725", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEI", "relevance_score": "0.166743", "ticker_sentiment_score": "0.184687", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BHAT", "relevance_score": "0.166743", "ticker_sentiment_score": "0.226725", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASNS", "relevance_score": "0.166743", "ticker_sentiment_score": "0.393854", "ticker_sentiment_label": "Bullish"}, {"ticker": "AMV", "relevance_score": "0.166743", "ticker_sentiment_score": "0.213187", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNAI", "relevance_score": "0.166743", "ticker_sentiment_score": "0.393854", "ticker_sentiment_label": "Bullish"}, {"ticker": "MULN", "relevance_score": "0.166743", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.083833", "ticker_sentiment_score": "0.097711", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGF", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.337744", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGMO", "relevance_score": "0.166743", "ticker_sentiment_score": "0.133739", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSE", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.091238", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.166743", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.247838", "ticker_sentiment_score": "0.092192", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.166743", "ticker_sentiment_score": "0.213187", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APM", "relevance_score": "0.247838", "ticker_sentiment_score": "0.157798", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLBX", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.214541", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMX", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.093439", "ticker_sentiment_label": "Neutral"}]}, {"title": "MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Cullinan Therapeutics  ( NASDAQ:CGEM ) ", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42684275/microstrategy-portland-general-electric-and-other-big-stocks-moving-lower-in-thursdays-pre-m", "time_published": "20241226T134928", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday. Shares of MicroStrategy Incorporated MSTR fell sharply in today's pre-market trading following the company's announcement to issue more shares to finance additional Bitcoin BTC/USD acquisitions.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/26/movers-image.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.109944, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GTN", "relevance_score": "0.374312", "ticker_sentiment_score": "-0.613117", "ticker_sentiment_label": "Bearish"}, {"ticker": "MSTR", "relevance_score": "0.535653", "ticker_sentiment_score": "-0.065798", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPCE", "relevance_score": "0.374312", "ticker_sentiment_score": "0.468271", "ticker_sentiment_label": "Bullish"}, {"ticker": "POR", "relevance_score": "0.374312", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.374312", "ticker_sentiment_score": "-0.613117", "ticker_sentiment_label": "Bearish"}, {"ticker": "DCTH", "relevance_score": "0.374312", "ticker_sentiment_score": "-0.613117", "ticker_sentiment_label": "Bearish"}, {"ticker": "GE", "relevance_score": "0.192694", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXC", "relevance_score": "0.374312", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.535653", "ticker_sentiment_score": "-0.024246", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lamb Weston Posts Weak Q2 Results, Joins Micron, Lennar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Akso Health  ( NASDAQ:AHG ) , Abacus Life  ( NASDAQ:ABL ) ", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42576985/lamb-weston-posts-weak-q2-results-joins-micron-lennar-and-other-big-stocks-moving-lower-in-t", "time_published": "20241219T132922", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Thursday. Shares of Lamb Weston Holdings, Inc. LW fell sharply in today's pre-market trading as the company posted downbeat quarterly results and lowered FY25 outlook.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/19/movers-image.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.031911, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHG", "relevance_score": "0.263942", "ticker_sentiment_score": "-0.497274", "ticker_sentiment_label": "Bearish"}, {"ticker": "QUBT", "relevance_score": "0.263942", "ticker_sentiment_score": "-0.09171", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEN", "relevance_score": "0.263942", "ticker_sentiment_score": "-0.259863", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DSGN", "relevance_score": "0.263942", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABLLL", "relevance_score": "0.133841", "ticker_sentiment_score": "-0.079317", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.263942", "ticker_sentiment_score": "0.228705", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LW", "relevance_score": "0.499789", "ticker_sentiment_score": "-0.203637", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Aethlon Medical  ( NASDAQ:AEMD ) , Abacus Life  ( NASDAQ:ABL ) ", "url": "https://www.benzinga.com/24/12/42571821/why-sangamo-therapeutics-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket", "time_published": "20241219T111536", "authors": ["Avi Kapoor"], "summary": "Shares of Sangamo Therapeutics, Inc. SGMO rose sharply in today's pre-market trading. Astellas and Sangamo Therapeutics disclosed Capsid license agreement to deliver genomic medicines for neurological diseases. Sangamo Therapeutics shares jumped 19.5% to $2.81 in the pre-market trading session.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/19/Intel--Cleanspark--Super-Micro-Computer-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.024469, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DALN", "relevance_score": "0.16849", "ticker_sentiment_score": "0.089094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.228275", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVNI", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.351831", "ticker_sentiment_label": "Bearish"}, {"ticker": "ELAB", "relevance_score": "0.16849", "ticker_sentiment_score": "0.418227", "ticker_sentiment_label": "Bullish"}, {"ticker": "MU", "relevance_score": "0.16849", "ticker_sentiment_score": "0.163309", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SLXN", "relevance_score": "0.16849", "ticker_sentiment_score": "0.228275", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LW", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.135074", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURR", "relevance_score": "0.16849", "ticker_sentiment_score": "0.228275", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MESO", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.10786", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.329551", "ticker_sentiment_score": "0.320198", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LITM", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.065197", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.447507", "ticker_sentiment_label": "Bearish"}, {"ticker": "ABLLL", "relevance_score": "0.084722", "ticker_sentiment_score": "-0.065245", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.240513", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APCX", "relevance_score": "0.16849", "ticker_sentiment_score": "0.333298", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRAX", "relevance_score": "0.16849", "ticker_sentiment_score": "-0.37155", "ticker_sentiment_label": "Bearish"}, {"ticker": "XCH", "relevance_score": "0.16849", "ticker_sentiment_score": "0.05244", "ticker_sentiment_label": "Neutral"}]}, {"title": "NVIDIA Opens BioNeMo to Scale Digital Biology for Global Biopharma and Scientific Industry - NVIDIA  ( NASDAQ:NVDA ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g42045591/nvidia-opens-bionemo-to-scale-digital-biology-for-global-biopharma-and-scientific-industry", "time_published": "20241118T183000", "authors": ["Globe Newswire"], "summary": "ATLANTA, Nov. 18, 2024 ( GLOBE NEWSWIRE ) -- SC24 -- NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source NVIDIA\u00ae BioNeMo\u2122 Framework to advance drug discovery and accelerate molecule design.", "banner_image": "https://ml.globenewswire.com/media/ad3b9553-6933-40b1-adfd-2ed199cd141c/small/nvidia-logo-jpg.jpg", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.206426, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.033468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.665473", "ticker_sentiment_score": "0.267298", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACN", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.078348", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.033468", "ticker_sentiment_score": "0.009486", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.033468", "ticker_sentiment_score": "0.094682", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in Multiple Upcoming Investor Conferences - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41937143/design-therapeutics-to-participate-in-multiple-upcoming-investor-conferences", "time_published": "20241113T130049", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. DSGN, a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in the following upcoming investor conferences:", "banner_image": "https://ml.globenewswire.com/media/bbfe687d-5236-42ea-8012-8ab435c6914d/small/designtx-logo-colored-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.113673, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.535653", "ticker_sentiment_score": "0.074734", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in Multiple Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2024/11/13/2980244/0/en/Design-Therapeutics-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html", "time_published": "20241113T130000", "authors": ["Design Therapeutics", "Inc."], "summary": "CARLSBAD, Calif., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in the following upcoming investor ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.064779, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.550532", "ticker_sentiment_score": "0.079244", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/24/09/g40790539/design-therapeutics-to-participate-in-the-2024-cantor-global-healthcare-conference", "time_published": "20240910T120000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Sept. 10, 2024 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. DSGN, a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on ...", "banner_image": "https://ml.globenewswire.com/media/bbfe687d-5236-42ea-8012-8ab435c6914d/small/designtx-logo-colored-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.12299, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.598621", "ticker_sentiment_score": "0.072621", "ticker_sentiment_label": "Neutral"}]}, {"title": "Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development - Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions - Palatin Techs  ( AMEX:PTN ) ", "url": "https://www.benzinga.com/partner/biotech/24/08/40599753/palatin-technologies-utilizing-the-melanocortin-system-as-the-basis-for-innovation-in-drug-develo", "time_published": "20240828T125438", "authors": ["Kyle Anthony"], "summary": "Palatin Technologies PTN, a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, received the first FDA approval for a melanocortin agent, for the treatment of hypoactive sexual desire disorder ( HSDD ) ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/28/Screenshot-2024-08-28-at-6-22-42PM.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.104011, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.02379", "ticker_sentiment_score": "0.062324", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Analysts Think Design Therapeutics  ( DSGN )  Could Surge 39.72%: Read This Before Placing a Bet", "url": "https://www.zacks.com/stock/news/2325016/wall-street-analysts-think-design-therapeutics-dsgn-could-surge-3972-read-this-before-placing-a-bet", "time_published": "20240821T135506", "authors": ["Zacks Equity Research"], "summary": "The consensus price target hints at a 39.7% upside potential for Design Therapeutics (DSGN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.21855, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.2842", "ticker_sentiment_score": "0.366274", "ticker_sentiment_label": "Bullish"}]}, {"title": "Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC\u2122 Portfolio", "url": "https://www.globenewswire.com/news-release/2024/08/05/2924213/0/en/Design-Therapeutics-Announces-Second-Quarter-2024-Financial-Results-and-Reviews-Near-term-Milestones-for-GeneTAC-Portfolio.html", "time_published": "20240805T120000", "authors": ["Inc.", "Design Therapeutics"], "summary": "Friedreich Ataxia ( FA ) and Fuchs Endothelial Corneal Dystrophy ( FECD ) Programs on Track and Advancing Toward Clinical Trials ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.155348, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.119532", "ticker_sentiment_score": "0.0807", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying - FTC Solar  ( NASDAQ:FTCI ) , Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/03/37930612/design-therapeutics-and-2-other-stocks-under-5-insiders-are-buying", "time_published": "20240326T113752", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/26/image48.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.259085, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FTCI", "relevance_score": "0.466325", "ticker_sentiment_score": "0.365901", "ticker_sentiment_label": "Bullish"}, {"ticker": "DSGN", "relevance_score": "0.466325", "ticker_sentiment_score": "0.268218", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OCUP", "relevance_score": "0.466325", "ticker_sentiment_score": "0.33418", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37610931/design-therapeutics-to-webcast-fourth-quarter-and-full-year-2023-financial-results-and-comprehensi", "time_published": "20240312T103000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., March 12, 2024 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. DSGN, a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that the company will host a conference call and live webcast on Tuesday, March 19, 2024, at 4:30 p.m.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.037092, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.579393", "ticker_sentiment_score": "0.081761", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update", "url": "https://www.globenewswire.com/news-release/2024/03/12/2844360/0/en/Design-Therapeutics-to-Webcast-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Comprehensive-Portfolio-Update.html", "time_published": "20240312T103000", "authors": ["Design Therapeutics", "Inc."], "summary": "CARLSBAD, Calif., March 12, 2024 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that the company will host a conference call and live webcast on Tuesday, March 19, 2024, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.04176, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.504646", "ticker_sentiment_score": "0.075455", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics, Inc.  ( DSGN )  Upgraded to Buy: Here's What You Should Know", "url": "https://www.zacks.com/stock/news/2199552/design-therapeutics-inc-dsgn-upgraded-to-buy-heres-what-you-should-know", "time_published": "20231218T170006", "authors": ["Zacks Equity Research"], "summary": "Design Therapeutics, Inc. (DSGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default277.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.301458, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.359014", "ticker_sentiment_score": "0.328856", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/23/10/g35203040/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20231011T193848", "authors": ["Globe Newswire"], "summary": "NEW YORK, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.012164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.056481", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeutics-inc---dsgn-301951325.html", "time_published": "20231009T230200", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.012224, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.433523", "ticker_sentiment_score": "0.180941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Nested Therapeutics to Present Preclinical Data for Novel, Potential Best-in-Class Inhibitor of the RAS/MAPK Pathway at 2023 AACR-NCI-EORTC Conference", "url": "https://www.prnewswire.com/news-releases/nested-therapeutics-to-present-preclinical-data-for-novel-potential-best-in-class-inhibitor-of-the-rasmapk-pathway-at-2023-aacr-nci-eortc-conference-301947339.html", "time_published": "20231004T161500", "authors": ["Inc.", "Nested Therapeutics"], "summary": "Nested Therapeutics to Present Preclinical Data for Novel, Potential Best-in-Class Inhibitor of the RAS/MAPK Pathway ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1914985/Nested_Therapeutics_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.199938, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.113597", "ticker_sentiment_score": "0.234421", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeutics-inc---dsgn-301943499.html", "time_published": "20230929T225400", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.012224, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.433523", "ticker_sentiment_score": "0.180941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/23/09/g34886606/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20230926T024907", "authors": ["Globe Newswire"], "summary": "NEW YORK, Sept. 25, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.012164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.056481", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://markets.businessinsider.com/news/stocks/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeutics-inc.-dsgn-1031978478", "time_published": "20230923T221500", "authors": ["NEWSFILE"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Design Therapeutics, Inc. ...", "banner_image": "https://api.newsfilecorp.com/newsinfo/181676/208", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.007314, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.416844", "ticker_sentiment_score": "0.056266", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/23/09/g34668118/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20230917T225420", "authors": ["Globe Newswire"], "summary": "NEW YORK, Sept. 17, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.012164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.056481", "ticker_sentiment_label": "Neutral"}]}, {"title": "Director At This Health Care Company Buys $14.00M of Stock - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/news/23/09/34323145/director-at-this-health-care-company-buys-14-00m-of-stock", "time_published": "20230907T150245", "authors": ["Benzinga Insights"], "summary": "Arsani William, Director at Design Therapeutics DSGN, reported a large insider buy on September 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that William purchased 700,000 shares of Design Therapeutics.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/insider_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.127802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.512093", "ticker_sentiment_score": "0.292647", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/23/09/g34181227/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20230901T185451", "authors": ["Globe Newswire"], "summary": "NEW YORK, Sept. 01, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.01217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.056481", "ticker_sentiment_label": "Neutral"}]}, {"title": "Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - ClearOne  ( NASDAQ:CLRO ) , Carmell Therapeutics  ( NASDAQ:CTCX ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/08/34142038/over-5m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggress", "time_published": "20230831T124034", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/31/image20.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.25369, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CLRO", "relevance_score": "0.414559", "ticker_sentiment_score": "0.165781", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSGN", "relevance_score": "0.414559", "ticker_sentiment_score": "0.287339", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TLS", "relevance_score": "0.414559", "ticker_sentiment_score": "0.427032", "ticker_sentiment_label": "Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeutics-inc---dsgn-301911579.html", "time_published": "20230828T221100", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.012224, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.433523", "ticker_sentiment_score": "0.180941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeutics-inc---dsgn-301904904.html", "time_published": "20230819T001500", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.012224, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.433523", "ticker_sentiment_score": "0.180941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/general/biotech/23/08/33862645/design-therapeutics-modified-dt-216-may-have-potential-but-analyst-awaits-further-developments", "time_published": "20230815T193235", "authors": ["Vandana Singh"], "summary": "RBC Capital Market downgraded Design Therapeutics Inc DSGN from Outperform to Sector Perform with a price target of $7, down from $23. The company reported initial results from the company's Phase 1 multiple-ascending dose clinical trial of DT-216 in patients with Friedrich ataxia.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/dsgn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.037733, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.485711", "ticker_sentiment_score": "0.406565", "ticker_sentiment_label": "Bullish"}]}, {"title": "Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher - Design Therapeutics  ( NASDAQ:DSGN ) , Delcath Systems  ( NASDAQ:DCTH ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33865408/nasdaq-falls-100-points-siyata-mobile-shares-spike-higher", "time_published": "20230815T190408", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The S&P 500, also fell, dropping, 0.87% to 4,450.59. Health care shares fell by just 0.2% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/image37.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.024174, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLTO", "relevance_score": "0.106778", "ticker_sentiment_score": "-0.038871", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYTA", "relevance_score": "0.106778", "ticker_sentiment_score": "0.4593", "ticker_sentiment_label": "Bullish"}, {"ticker": "BACHY", "relevance_score": "0.053509", "ticker_sentiment_score": "-0.021011", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.053509", "ticker_sentiment_score": "-0.187767", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DSGN", "relevance_score": "0.106778", "ticker_sentiment_score": "0.060546", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVOS", "relevance_score": "0.106778", "ticker_sentiment_score": "0.243102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCTH", "relevance_score": "0.106778", "ticker_sentiment_score": "0.178378", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HD", "relevance_score": "0.106778", "ticker_sentiment_score": "0.336351", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FXLV", "relevance_score": "0.106778", "ticker_sentiment_score": "0.213467", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Shares of Design Therapeutics Are Plummeting on Tuesday", "url": "https://www.fool.com/investing/2023/08/15/why-shares-of-design-therapeutics-are-plummeting-o/", "time_published": "20230815T190200", "authors": ["Jim Halley"], "summary": "The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F743866%2F22_03_21-an-oil-well-with-clean-energy-wind-turbines-in-the-background-_gettyimages-1263933136.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.035552, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.25168", "ticker_sentiment_score": "0.098271", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Down 2%; Home Depot Posts Upbeat Earnings - Design Therapeutics  ( NASDAQ:DSGN ) , Delcath Systems  ( NASDAQ:DCTH ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33862485/crude-oil-down-2-home-depot-posts-upbeat-earnings", "time_published": "20230815T160012", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P 500, also fell, dropping, 0.76% to 4,455.45. Health care shares fell by just 0.1% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.026593, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLTO", "relevance_score": "0.107255", "ticker_sentiment_score": "-0.038927", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYTA", "relevance_score": "0.107255", "ticker_sentiment_score": "0.459906", "ticker_sentiment_label": "Bullish"}, {"ticker": "BACHY", "relevance_score": "0.053749", "ticker_sentiment_score": "-0.021012", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.053749", "ticker_sentiment_score": "-0.187792", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DSGN", "relevance_score": "0.107255", "ticker_sentiment_score": "0.060634", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVOS", "relevance_score": "0.107255", "ticker_sentiment_score": "0.243457", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCTH", "relevance_score": "0.107255", "ticker_sentiment_score": "0.178641", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HD", "relevance_score": "0.107255", "ticker_sentiment_score": "0.33683", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FXLV", "relevance_score": "0.107255", "ticker_sentiment_score": "0.213781", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Falls Over 200 Points; US Retail Sales Top Expectations - Design Therapeutics  ( NASDAQ:DSGN ) , Delcath Systems  ( NASDAQ:DCTH ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33859650/dow-falls-over-200-points-us-retail-sales-top-expectations", "time_published": "20230815T140139", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell 0.47% to 13,723.41. The S&P 500, also fell, dropping, 0.61% to 4,462.38.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/image27_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.026563, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GLTO", "relevance_score": "0.120431", "ticker_sentiment_score": "-0.040647", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYTA", "relevance_score": "0.120431", "ticker_sentiment_score": "0.477873", "ticker_sentiment_label": "Bullish"}, {"ticker": "BACHY", "relevance_score": "0.060388", "ticker_sentiment_score": "-0.021098", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.120431", "ticker_sentiment_score": "0.063325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVOS", "relevance_score": "0.120431", "ticker_sentiment_score": "0.2542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCTH", "relevance_score": "0.120431", "ticker_sentiment_score": "0.186612", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FXLV", "relevance_score": "0.120431", "ticker_sentiment_score": "0.223275", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Is Design Therapeutics Stock Moving Lower Today? - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/general/biotech/23/08/33855730/why-is-design-therapeutics-stock-moving-lower-today", "time_published": "20230815T130454", "authors": ["Vandana Singh"], "summary": "Design Therapeutics Inc DSGN reported initial results from the company's Phase 1 multiple-ascending dose ( MAD ) clinical trial of DT-216 in patients with Friedrich ataxia ( FA ) .", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/aapharma_2.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.072753, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.42503", "ticker_sentiment_score": "-0.073691", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket - Aptevo Therapeutics  ( NASDAQ:APVO ) , Altisource Asset Mgmt  ( AMEX:AAMC ) ", "url": "https://www.benzinga.com/news/23/08/33856601/why-delcath-systems-shares-are-trading-higher-by-around-58-here-are-20-stocks-moving-premarket", "time_published": "20230815T121728", "authors": ["Lisa Levin"], "summary": "Delcath Systems, Inc. DCTH shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT\u2122 for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Sonim Technologies, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/delcath_systems_-_logo_.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.938238"}], "overall_sentiment_score": 0.051122, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LL", "relevance_score": "0.078611", "ticker_sentiment_score": "0.172863", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GETY", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.229509", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OPRX", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.259032", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TTOO", "relevance_score": "0.156461", "ticker_sentiment_score": "0.350552", "ticker_sentiment_label": "Bullish"}, {"ticker": "DCTH", "relevance_score": "0.156461", "ticker_sentiment_score": "0.185156", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GROV", "relevance_score": "0.156461", "ticker_sentiment_score": "0.321239", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MGOL", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.354356", "ticker_sentiment_label": "Bearish"}, {"ticker": "SYTA", "relevance_score": "0.156461", "ticker_sentiment_score": "0.390889", "ticker_sentiment_label": "Bullish"}, {"ticker": "GMVD", "relevance_score": "0.156461", "ticker_sentiment_score": "0.227151", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APVO", "relevance_score": "0.23281", "ticker_sentiment_score": "-0.46042", "ticker_sentiment_label": "Bearish"}, {"ticker": "DSGN", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.111916", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.192013", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TFFP", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.14985", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.044008", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONM", "relevance_score": "0.156461", "ticker_sentiment_score": "0.134151", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.23281", "ticker_sentiment_score": "0.212338", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:SNM", "relevance_score": "0.078611", "ticker_sentiment_score": "0.104519", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Kanzhun  ( NASDAQ:BZ ) , Calliditas Therapeutics  ( NASDAQ:CALT ) ", "url": "https://www.benzinga.com/news/23/08/33854726/design-therapeutics-getty-images-sea-limited-and-other-big-stocks-moving-lower-in-tuesdays-pre-marke", "time_published": "20230815T110026", "authors": ["Lisa Levin"], "summary": "U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today's pre-market trading session. Design Therapeutics, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/15/design_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.210697, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "DFS", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.183259", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GETY", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.330352", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SE", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.520122", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOL", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.45695", "ticker_sentiment_label": "Bearish"}, {"ticker": "DSGN", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.043668", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRHC", "relevance_score": "0.382925", "ticker_sentiment_score": "-0.281935", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VNO", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.493771", "ticker_sentiment_label": "Bearish"}, {"ticker": "BZ", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.365651", "ticker_sentiment_label": "Bearish"}, {"ticker": "CALT", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.056181", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTH", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.493771", "ticker_sentiment_label": "Bearish"}]}, {"title": "Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated - Biogen  ( NASDAQ:BIIB ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33444357/reatas-acquisition-fits-biogens-strategy-despite-high-cost-analyst-says-high-level-", "time_published": "20230728T155617", "authors": ["Vandana Singh"], "summary": "Earlier today, Biogen Inc BIIB agreed to acquire Reata Pharmaceuticals Inc RETA for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/28/aapharma_5.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.162687, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SLDB", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RETA", "relevance_score": "0.280615", "ticker_sentiment_score": "0.481365", "ticker_sentiment_label": "Bullish"}, {"ticker": "LRMR", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.718897", "ticker_sentiment_score": "0.314394", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - American Equity Inv  ( NYSE:AEL ) , Adicet Bio  ( NASDAQ:ACET ) ", "url": "https://www.benzinga.com/news/23/06/33021667/why-american-equity-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket", "time_published": "20230627T121937", "authors": ["Lisa Levin"], "summary": "Surgalign Holdings, Inc. SRGA shares surged 49.8% to $0.3401 in pre-market trading after dropping around 19% on Monday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/27/image_7.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.143385, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MEDS", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.1334", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCFT", "relevance_score": "0.12645", "ticker_sentiment_score": "0.08883", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.249744", "ticker_sentiment_score": "0.053698", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEL", "relevance_score": "0.12645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.12645", "ticker_sentiment_score": "0.10075", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMS", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.218739", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IRNT", "relevance_score": "0.12645", "ticker_sentiment_score": "0.194179", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIEW", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.029989", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACET", "relevance_score": "0.188683", "ticker_sentiment_score": "0.022131", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOV", "relevance_score": "0.188683", "ticker_sentiment_score": "-0.12695", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.188683", "ticker_sentiment_score": "0.21284", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSGN", "relevance_score": "0.12645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.188683", "ticker_sentiment_score": "0.117927", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRSH", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.013864", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOL", "relevance_score": "0.188683", "ticker_sentiment_score": "0.19824", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZYNE", "relevance_score": "0.12645", "ticker_sentiment_score": "0.323663", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RIDE", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.215452", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ASTC", "relevance_score": "0.188683", "ticker_sentiment_score": "0.259775", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SRGA", "relevance_score": "0.188683", "ticker_sentiment_score": "0.253949", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/05/31/2679170/0/en/Design-Therapeutics-to-Present-at-the-2023-Jefferies-Healthcare-Conference.html", "time_published": "20230531T103000", "authors": ["Inc.", "Design Therapeutics"], "summary": "CARLSBAD, Calif., May 31, 2023 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that management will present at the 2023 Jefferies Healthcare Conference on ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.023456, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.495015", "ticker_sentiment_score": "-0.068652", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/g32642653/design-therapeutics-to-present-at-the-2023-jefferies-healthcare-conference", "time_published": "20230531T103000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., May 31, 2023 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. DSGN, a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that management will present at the 2023 Jefferies Healthcare Conference on Wednesday, June ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.021082, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.323078", "ticker_sentiment_score": "-0.063531", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present Preclinical Data on its GeneTAC\u2122 Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023 - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/23/04/g31952395/design-therapeutics-to-present-preclinical-data-on-its-genetac-small-molecule-dt-168-for-the-treat", "time_published": "20230424T103000", "authors": ["Globe Newswire"], "summary": "Treatment with DT-168 Eye Drops Reduced Nuclear Foci and Significantly Improved Mis-Splicing In Vitro Company On-track to Submit Investigational New Drug Application for DT-168 in the Second Half of 2023 CARLSBAD, Calif., April 24, 2023 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.090379, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.06623", "ticker_sentiment_score": "0.010037", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present Preclinical Data on its GeneTAC\u2122 Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023", "url": "https://www.globenewswire.com/news-release/2023/04/24/2652505/0/en/Design-Therapeutics-to-Present-Preclinical-Data-on-its-GeneTAC-Small-Molecule-DT-168-for-the-Treatment-of-Fuchs-Endothelial-Corneal-Dystrophy-at-ARVO-2023.html", "time_published": "20230424T103000", "authors": ["Design Therapeutics", "Inc."], "summary": "Treatment with DT-168 Eye Drops Reduced Nuclear Foci and Significantly Improved Mis-Splicing In Vitro ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.088106, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.101725", "ticker_sentiment_score": "-0.008641", "ticker_sentiment_label": "Neutral"}]}, {"title": "First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday - Aspen Aerogels  ( NYSE:ASPN ) , Blend Labs  ( NYSE:BLND ) ", "url": "https://www.benzinga.com/news/23/03/31400166/first-republic-bank-blend-labs-purple-innovation-and-other-big-stocks-moving-lower-on-friday", "time_published": "20230317T155529", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today's session. Blend Labs, Inc. BLND dropped 36.5% to $0.9338 after the company reported worse-than-expected Q4 adjusted EPS and sales results. Nexters Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/17/image21.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.248356, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "PACW", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.525384", "ticker_sentiment_label": "Bearish"}, {"ticker": "SRPT", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.110973", "ticker_sentiment_score": "-0.066843", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.581063", "ticker_sentiment_label": "Bearish"}, {"ticker": "MCB", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.581063", "ticker_sentiment_label": "Bearish"}, {"ticker": "ASPN", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDEV", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.089406", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLG", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KARO", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.126382", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIX", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.101421", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.06658", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTK", "relevance_score": "0.219809", "ticker_sentiment_score": "-0.30948", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMAX", "relevance_score": "0.324495", "ticker_sentiment_score": "-0.386957", "ticker_sentiment_label": "Bearish"}, {"ticker": "BLND", "relevance_score": "0.219809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ", "url": "https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday", "time_published": "20230313T145550", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today's session. Provention Bio, Inc. PRVB shares gained 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/13/image15.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.252893, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.427622", "ticker_sentiment_label": "Bullish"}, {"ticker": "HGMCF", "relevance_score": "0.08183", "ticker_sentiment_score": "-0.031282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.162802", "ticker_sentiment_score": "0.296174", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENVX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFI", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.04352", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRVB", "relevance_score": "0.162802", "ticker_sentiment_score": "0.371688", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.08183", "ticker_sentiment_score": "0.106086", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.242084", "ticker_sentiment_score": "0.214843", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSGN", "relevance_score": "0.162802", "ticker_sentiment_score": "0.450092", "ticker_sentiment_label": "Bullish"}, {"ticker": "ZYXI", "relevance_score": "0.162802", "ticker_sentiment_score": "0.53477", "ticker_sentiment_label": "Bullish"}, {"ticker": "SGEN", "relevance_score": "0.162802", "ticker_sentiment_score": "0.13894", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.08183", "ticker_sentiment_score": "0.287233", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MARA", "relevance_score": "0.242084", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AG", "relevance_score": "0.162802", "ticker_sentiment_score": "0.333681", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.162802", "ticker_sentiment_score": "0.141622", "ticker_sentiment_label": "Neutral"}, {"ticker": "KGC", "relevance_score": "0.162802", "ticker_sentiment_score": "0.21126", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CIFR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCN", "relevance_score": "0.242084", "ticker_sentiment_score": "0.342533", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AU", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.04352", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALT", "relevance_score": "0.162802", "ticker_sentiment_score": "0.229926", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KPTI", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.037305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIM", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.146682", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.242084", "ticker_sentiment_score": "-0.058468", "ticker_sentiment_label": "Neutral"}]}, {"title": "OpenAI's 37-year-old CEO bet $180 million on a little-known biotech startup that's trying to help people live 10 years longer", "url": "https://africa.businessinsider.com/science/openais-37-year-old-ceo-bet-dollar180-million-on-a-little-known-biotech-startup-thats/e7s4s6h", "time_published": "20230309T134807", "authors": [], "summary": "OpenAI's 37-year-old CEO bet $180 million on a little-known biotech ... - Business Insider Africa ...", "banner_image": "https://ocdn.eu/pulscms-transforms/1/dYjktkuTURBXy80ODA4NDAyNi00M2M1LTQ0ZTItYTZkYi1lMTIxMDYzNzg3ODMuanBlZ5GTBc0DFs0Brg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "africa.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.189308, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.090816", "ticker_sentiment_score": "0.209783", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "OpenAI's 37-year-old CEO bet $180 million on a little-known biotech startup that's trying to help people live 10 years longer", "url": "https://www.businessinsider.com/openai-ceo-sam-altman-investment-longevity-startup-retro-2023-3", "time_published": "20230309T134807", "authors": ["Yeji Jesse Lee"], "summary": "OpenAI CEO's $180 Million Bet on Longevity Startup Retro - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.196307, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.079392", "ticker_sentiment_score": "0.204361", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference", "url": "https://www.globenewswire.com/news-release/2023/02/08/2603742/0/en/Design-Therapeutics-to-Participate-in-the-SVB-Securities-Virtual-Global-Biopharma-Conference.html", "time_published": "20230208T113000", "authors": ["Design Therapeutics", "Inc."], "summary": "CARLSBAD, Calif., Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that Jo\u00e3o Siffert, M.D., president and chief executive officer, will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.002355, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.468029", "ticker_sentiment_score": "-0.027238", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/23/02/g30803612/design-therapeutics-to-participate-in-the-svb-securities-virtual-global-biopharma-conference", "time_published": "20230208T113000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.002351, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.305058", "ticker_sentiment_score": "0.032955", "ticker_sentiment_label": "Neutral"}]}, {"title": "DESIGN ALERT: Bragar Eagel & Squire, P.C. is Investigating Design Therapeutics, Inc. on Behalf of Design Stockholders and Encourages Investors to Contact the Firm - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/22/12/g30244082/design-alert-bragar-eagel-squire-p-c-is-investigating-design-therapeutics-inc-on-behalf-of-design-", "time_published": "20221231T020100", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 30, 2022 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN on behalf of Design stockholders.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.043451, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.25168", "ticker_sentiment_score": "-0.107257", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/22/12/g30195737/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20221225T015842", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 24, 2022 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": -0.031602, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "MillerKnoll, Cleveland-Cliffs And Some Other Big Stocks Moving Higher On Thursday - AMC Entertainment  ( NYSE:AMC ) , Alvotech  ( NASDAQ:ALVO ) ", "url": "https://www.benzinga.com/news/22/12/30175977/millerknoll-cleveland-cliffs-and-some-other-big-stocks-moving-higher-on-thursday", "time_published": "20221222T155706", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Thursday. Here are some big stocks recording gains in today's session. AMC Entertainment Holdings, Inc. APE jumped 77% to $1.21. AMC Entertainment Holdings Inc AMC announced an equity capital raise and a debt for equity ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/22/image30.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.14802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATXS", "relevance_score": "0.554365", "ticker_sentiment_score": "0.335942", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALVO", "relevance_score": "0.388879", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLF", "relevance_score": "0.388879", "ticker_sentiment_score": "0.294751", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APE", "relevance_score": "0.554365", "ticker_sentiment_score": "-0.024095", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.729309", "ticker_sentiment_label": "Bullish"}, {"ticker": "MLKN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.510262", "ticker_sentiment_label": "Bullish"}]}, {"title": "Complementary and Alternative Medicine Market to Experience Substantial Growth of USD 477.29 Billion by 2029, Size, Share, Growth Rate, Demand, Opportunities and Competitive Landscape", "url": "https://www.prnewswire.com/news-releases/complementary-and-alternative-medicine-market-to-experience-substantial-growth-of-usd-477-29-billion-by-2029--size-share-growth-rate-demand-opportunities-and-competitive-landscape-301708943.html", "time_published": "20221222T111500", "authors": ["Data Bridge Market Research"], "summary": "Complementary and Alternative Medicine Market to Experience ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.287816, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APG", "relevance_score": "0.019317", "ticker_sentiment_score": "0.033332", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.019317", "ticker_sentiment_score": "0.045747", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.019317", "ticker_sentiment_score": "0.076955", "ticker_sentiment_label": "Neutral"}]}, {"title": "$7.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying - Design Therapeutics  ( NASDAQ:DSGN ) , Flowers Foods  ( NYSE:FLO ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/22/12/30157559/7-5-million-bet-on-this-biotechnology-stock-check-out-these-3-stocks-insiders-are-buying", "time_published": "20221221T112538", "authors": ["Lisa Levin"], "summary": "Although US stocks closed mostly higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/21/image10.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.242332, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FLO", "relevance_score": "0.495015", "ticker_sentiment_score": "0.370648", "ticker_sentiment_label": "Bullish"}, {"ticker": "DSGN", "relevance_score": "0.495015", "ticker_sentiment_score": "0.310282", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN", "url": "https://www.benzinga.com/pressreleases/22/12/g30014950/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-design-therapeu", "time_published": "20221208T212734", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 08, 2022 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. ( \"Design\" or the \"Company\" ) DSGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": -0.031602, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.280615", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results - Ciena  ( NYSE:CIEN ) , Agora  ( NASDAQ:API ) ", "url": "https://www.benzinga.com/news/22/12/30013286/s-p-500-rises-0-5-ciena-posts-upbeat-q4-results", "time_published": "20221208T194133", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday. The Dow traded up 0.27% to 33,689.58 while the NASDAQ rose 0.92% to 11,059.06. The S&P 500 also rose, gaining, 0.54% to 3,955.30.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/08/image21_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.031442, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CIEN", "relevance_score": "0.199037", "ticker_sentiment_score": "-0.082479", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOMO", "relevance_score": "0.13347", "ticker_sentiment_score": "0.441679", "ticker_sentiment_label": "Bullish"}, {"ticker": "PHVS", "relevance_score": "0.13347", "ticker_sentiment_score": "-0.020765", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.13347", "ticker_sentiment_score": "0.183697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSGN", "relevance_score": "0.13347", "ticker_sentiment_score": "0.046431", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLMD", "relevance_score": "0.13347", "ticker_sentiment_score": "0.10343", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.06697", "ticker_sentiment_score": "0.154454", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "API", "relevance_score": "0.13347", "ticker_sentiment_score": "0.183697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EIGR", "relevance_score": "0.13347", "ticker_sentiment_score": "-0.164717", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RENT", "relevance_score": "0.13347", "ticker_sentiment_score": "0.351868", "ticker_sentiment_label": "Bullish"}]}, {"title": "Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher - Ciena  ( NYSE:CIEN ) , Agora  ( NASDAQ:API ) ", "url": "https://www.benzinga.com/news/earnings/22/12/30011050/nasdaq-gains-100-points-rent-the-runway-shares-spike-higher", "time_published": "20221208T171209", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. The Dow traded up 0.61% to 33,803.12 while the NASDAQ rose 0.93% to 11,060.62. The S&P 500 also rose, gaining, 0.63% to 3,958.60.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/08/image38.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.064791, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CIEN", "relevance_score": "0.143415", "ticker_sentiment_score": "0.190828", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MOMO", "relevance_score": "0.143415", "ticker_sentiment_score": "0.456549", "ticker_sentiment_label": "Bullish"}, {"ticker": "PHVS", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.021619", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.143415", "ticker_sentiment_score": "0.048339", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLMD", "relevance_score": "0.143415", "ticker_sentiment_score": "0.107494", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.072", "ticker_sentiment_score": "0.155149", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "API", "relevance_score": "0.143415", "ticker_sentiment_score": "0.190828", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EIGR", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.171402", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RENT", "relevance_score": "0.143415", "ticker_sentiment_score": "0.364572", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday - Cano Health  ( NYSE:CANO ) , The Chefs' Warehouse  ( NASDAQ:CHEF ) ", "url": "https://www.benzinga.com/news/22/12/30009897/chefs-warehouse-chart-industries-and-some-other-big-stocks-moving-lower-on-thursday", "time_published": "20221208T160409", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today's session. Design Therapeutics, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/08/image-chefs_warehouse.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.11838, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CANO", "relevance_score": "0.290607", "ticker_sentiment_score": "-0.293686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LNC", "relevance_score": "0.290607", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.252161", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MERC", "relevance_score": "0.290607", "ticker_sentiment_score": "0.111996", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.290607", "ticker_sentiment_score": "-0.402467", "ticker_sentiment_label": "Bearish"}, {"ticker": "CUTR", "relevance_score": "0.290607", "ticker_sentiment_score": "-0.267912", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMPS", "relevance_score": "0.290607", "ticker_sentiment_score": "-0.676959", "ticker_sentiment_label": "Bearish"}, {"ticker": "GTLS", "relevance_score": "0.423843", "ticker_sentiment_score": "-0.089919", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.290607", "ticker_sentiment_score": "0.328831", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MMAT", "relevance_score": "0.290607", "ticker_sentiment_score": "-0.676959", "ticker_sentiment_label": "Bearish"}, {"ticker": "CHEF", "relevance_score": "0.290607", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVMD", "relevance_score": "0.423843", "ticker_sentiment_score": "-0.399212", "ticker_sentiment_label": "Bearish"}, {"ticker": "SNY", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.189072", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Dow Rises 150 Points; US Jobless Claims Increase To 230,000 - Ciena  ( NYSE:CIEN ) , Ardmore Shipping  ( NYSE:ASC ) ", "url": "https://www.benzinga.com/news/earnings/22/12/30008363/dow-rises-150-points-us-jobless-claims-increase-to-230-000", "time_published": "20221208T150324", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.49% to 33,763.59 while the NASDAQ rose 0.35% to 10,997.36. The S&P 500 also rose, gaining, 0.43% to 3,950.66.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/08/image21.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.021769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CIEN", "relevance_score": "0.155451", "ticker_sentiment_score": "0.478858", "ticker_sentiment_label": "Bullish"}, {"ticker": "MOMO", "relevance_score": "0.155451", "ticker_sentiment_score": "0.475261", "ticker_sentiment_label": "Bullish"}, {"ticker": "PHVS", "relevance_score": "0.155451", "ticker_sentiment_score": "-0.022718", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASC", "relevance_score": "0.155451", "ticker_sentiment_score": "0.303412", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RIG", "relevance_score": "0.155451", "ticker_sentiment_score": "0.303412", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSGN", "relevance_score": "0.155451", "ticker_sentiment_score": "0.050792", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLMD", "relevance_score": "0.155451", "ticker_sentiment_score": "0.112766", "ticker_sentiment_label": "Neutral"}, {"ticker": "EIGR", "relevance_score": "0.155451", "ticker_sentiment_score": "-0.179951", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday - Ambarella  ( NASDAQ:AMBA ) , Apellis Pharmaceuticals  ( NASDAQ:APLS ) ", "url": "https://www.benzinga.com/news/22/11/29799908/foot-locker-ross-stores-palo-alto-networks-and-other-big-gainers-from-friday", "time_published": "20221121T093732", "authors": ["Lisa Levin"], "summary": "U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. Clearfield, Inc. CLFD shares climbed 26.7% to close at $117.94 after the company reported better-than-expected Q4 results. IVERIC bio, ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/21/image-palo_alto_networks.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.96136"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.315954, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LPRO", "relevance_score": "0.125789", "ticker_sentiment_score": "0.25553", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATKR", "relevance_score": "0.125789", "ticker_sentiment_score": "0.383985", "ticker_sentiment_label": "Bullish"}, {"ticker": "SCU", "relevance_score": "0.125789", "ticker_sentiment_score": "0.24271", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FL", "relevance_score": "0.125789", "ticker_sentiment_score": "0.349497", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STNEV", "relevance_score": "0.063091", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLS", "relevance_score": "0.125789", "ticker_sentiment_score": "0.182045", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INDI", "relevance_score": "0.187705", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISEE", "relevance_score": "0.125789", "ticker_sentiment_score": "0.091305", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPS", "relevance_score": "0.125789", "ticker_sentiment_score": "0.232216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NUTX", "relevance_score": "0.125789", "ticker_sentiment_score": "0.314812", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "POND", "relevance_score": "0.125789", "ticker_sentiment_score": "0.314812", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MATW", "relevance_score": "0.125789", "ticker_sentiment_score": "0.41595", "ticker_sentiment_label": "Bullish"}, {"ticker": "AMBA", "relevance_score": "0.125789", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.187705", "ticker_sentiment_score": "-0.007936", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVH", "relevance_score": "0.187705", "ticker_sentiment_score": "0.324918", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EDU", "relevance_score": "0.125789", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLFD", "relevance_score": "0.125789", "ticker_sentiment_score": "0.356412", "ticker_sentiment_label": "Bullish"}, {"ticker": "ROST", "relevance_score": "0.125789", "ticker_sentiment_score": "0.41026", "ticker_sentiment_label": "Bullish"}, {"ticker": "CNC", "relevance_score": "0.063091", "ticker_sentiment_score": "0.222329", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARDX", "relevance_score": "0.187705", "ticker_sentiment_score": "0.037567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESSC", "relevance_score": "0.063091", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.125789", "ticker_sentiment_score": "0.249704", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Design Therapeutics to Present Preclinical Data Highlighting the Potential of its GeneTAC\u2122 Small Molecule, DT-216, for the Treatment of Friedreich Ataxia at ICAR 2022 - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29295735/design-therapeutics-to-present-preclinical-data-highlighting-the-potential-of-its-genetac-small-mo", "time_published": "20221017T200500", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Oct. 17, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.134908, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.072987", "ticker_sentiment_score": "0.01007", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present at the 2022 Jefferies Cell and Genetic Medicine Summit", "url": "https://www.globenewswire.com/news-release/2022/09/22/2520831/0/en/Design-Therapeutics-to-Present-at-the-2022-Jefferies-Cell-and-Genetic-Medicine-Summit.html", "time_published": "20220922T103000", "authors": ["Inc.", "Design Therapeutics"], "summary": "CARLSBAD, Calif., Sept. 22, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that Jo\u00e3o Siffert, M.D., president and chief executive officer, and Sean ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.078976, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.546745", "ticker_sentiment_score": "0.092309", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Design Therapeutics  ( NASDAQ:DSGN ) ", "url": "https://www.benzinga.com/pressreleases/22/09/g28960870/design-therapeutics-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit", "time_published": "20220922T103000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Sept. 22, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.071964, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.358152", "ticker_sentiment_score": "-0.046706", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/08/03/2491131/0/en/Design-Therapeutics-to-Participate-in-the-2022-Wedbush-PacGrow-Virtual-Healthcare-Conference.html", "time_published": "20220803T103000", "authors": ["Design Therapeutics", "Inc."], "summary": "CARLSBAD, Calif., Aug. 03, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that Jo\u00e3o Siffert, M.D., president and chief executive officer, and Sean ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.081304, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.546745", "ticker_sentiment_score": "0.095612", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/08/g28326477/design-therapeutics-to-participate-in-the-2022-wedbush-pacgrow-virtual-healthcare-conference", "time_published": "20220803T103000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., Aug. 03, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.07429, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.358152", "ticker_sentiment_score": "-0.051624", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/06/01/2454005/0/en/Design-Therapeutics-to-Present-at-the-2022-Jefferies-Healthcare-Conference.html", "time_published": "20220601T103000", "authors": ["Design Therapeutics", "Inc."], "summary": "CARLSBAD, Calif., June 01, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( Nasdaq: DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that Jo\u00e3o Siffert, M.D., president and chief executive officer, will present", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.013844, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.548255", "ticker_sentiment_score": "0.013844", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/06/g27493362/design-therapeutics-to-present-at-the-2022-jefferies-healthcare-conference", "time_published": "20220601T103000", "authors": ["Globe Newswire"], "summary": "CARLSBAD, Calif., June 01, 2022 ( GLOBE NEWSWIRE ) -- Design Therapeutics, Inc. ( NASDAQ:DSGN ) , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that Jo\u00e3o Siffert, M.D., president and chief executive officer, will present", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.053545, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.355333", "ticker_sentiment_score": "0.001167", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article", "time_published": "20220511T162815", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 807 companies reached new 52-week lows.\nThings to Consider About Today's 52-Week Lows:\nAmazon.com  ( NASDAQ:AMZN )  was the largest company by market cap to set a new 52-week low.\nGames & Esports  ( NASDAQ:GEEXW )  was the smallest company by market cap to set a new 52-week low.\nView  ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8443.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.026939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00124", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.036124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003313", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000149", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002042", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000991", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVID", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.370079", "ticker_sentiment_label": "Bearish"}, {"ticker": "SCOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007315", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008312", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004985", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.006905", "ticker_sentiment_score": "0.046669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006647", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028036", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.006905", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.435265", "ticker_sentiment_label": "Bearish"}, {"ticker": "AZRE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007661", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010696", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.569147", "ticker_sentiment_label": "Bearish"}, {"ticker": "VITL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01899", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002672", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006481", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000956", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.030942", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006892", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006208", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027974", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTER", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001811", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004785", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003781", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033286", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.032128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007747", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014035", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.026043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002584", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030553", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.102966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.018006", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.083313", "ticker_sentiment_label": "Neutral"}, {"ticker": "DH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002316", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01368", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.114162", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001387", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002708", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.041261", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001014", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029453", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.503669", "ticker_sentiment_label": "Bearish"}, {"ticker": "ABEO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010621", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.044931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057114", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025648", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.442405", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEJU", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNGX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00338", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010371", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFMD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033985", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008683", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001147", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.029975", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031721", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006969", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005509", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002347", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.026602", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000946", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003622", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001759", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002882", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01973", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002991", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015008", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006371", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004448", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003716", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005806", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032353", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.274715", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VERI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006905", "ticker_sentiment_score": "-7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NABL", "relevance_score": "0.01381", "ticker_sentiment_score": "-0.065212", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.035094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.017236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004494", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005494", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.027744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.380308", "ticker_sentiment_label": "Bearish"}, {"ticker": "YTEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020472", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03797", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.199176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SBTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008026", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00697", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.284624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033445", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.020713", "ticker_sentiment_score": "-0.00707", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001403", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029958", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053345", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.395079", "ticker_sentiment_label": "Bearish"}, {"ticker": "IONQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000885", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.057018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013737", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002159", "ticker_sentiment_label": "Neutral"}, {"ticker": "KD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000517", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00385", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAMOD", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.011888", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.201653", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014804", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.01381", "ticker_sentiment_score": "0.000537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.034535", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002931", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00339", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014879", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005779", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02828", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008229", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009155", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04243", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.358226", "ticker_sentiment_label": "Bearish"}, {"ticker": "TARA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00569", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006707", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.360118", "ticker_sentiment_label": "Bearish"}, {"ticker": "LAW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00929", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020967", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004281", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.006905", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003453", "ticker_sentiment_score": "0.131467", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005482", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029909", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020147", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005557", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003453", "ticker_sentiment_score": "0.008905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392024", "ticker_sentiment_label": "Bearish"}, {"ticker": "SMMT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010153", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011101", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000751", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019578", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015302", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01087", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003034", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007657", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006713", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.018388", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003455", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.066657", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.219042", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009159", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031329", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003443", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "OM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.03401", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021611", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033908", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02022", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005958", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004778", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRPX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.042368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006722", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006844", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005504", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.003453", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.019138", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNFT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007461", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTOS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004453", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001344", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007561", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006905", "ticker_sentiment_score": "4.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013924", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTIX", "relevance_score": "0.006905", "ticker_sentiment_score": "5.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029837", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009979", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSFE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.066369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017007", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006269", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02275", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002829", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.354538", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00193", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.259224", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MIR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004637", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.074059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004011", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.024874", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001667", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012462", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003477", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005184", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.010357", "ticker_sentiment_score": "0.001464", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "KGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012165", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004396", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019067", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000834", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003971", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001533", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RIOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02771", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.083853", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.031917", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.041747", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEPG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007498", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.029087", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011377", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.298818", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PZZA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001777", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009522", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.004382", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004749", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001507", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008075", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009289", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392113", "ticker_sentiment_label": "Bearish"}, {"ticker": "FBIO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002737", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.028695", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.039738", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011907", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009098", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002578", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021993", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007203", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.362989", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCTY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006714", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014569", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OUST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.294166", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORMP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000939", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007505", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.374918", "ticker_sentiment_label": "Bearish"}, {"ticker": "SFIX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.045373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004172", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.285345", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HYPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001889", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04092", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEWR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010603", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02631", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001556", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0152", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009431", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007666", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002913", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005884", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.059974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004692", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007552", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.006905", "ticker_sentiment_score": "3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000267", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.30025", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TNYA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.021404", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011834", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005064", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.280779", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FVRR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.332594", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ELAN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005139", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007599", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.303151", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EAR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.515459", "ticker_sentiment_label": "Bearish"}, {"ticker": "ZS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002864", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLKB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.038783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009183", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00365", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003406", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.044645", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRZE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIDM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033794", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TELA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICHR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019517", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015065", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.185111", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00253", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003239", "ticker_sentiment_label": "Neutral"}, {"ticker": "POLA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.473604", "ticker_sentiment_label": "Bearish"}, {"ticker": "BRSYF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.009217", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.065524", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003907", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNSO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003669", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010652", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005464", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006496", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012732", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009064", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009894", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.017179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIBS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.025121", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019209", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.542631", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOEV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006919", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.46795", "ticker_sentiment_label": "Bearish"}, {"ticker": "TACT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005671", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGPPF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.001751", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.303128", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HLF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030714", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01328", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009974", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.062454", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006434", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017918", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002596", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003579", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005085", "ticker_sentiment_label": "Neutral"}, {"ticker": "HURC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025491", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004826", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009901", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003009", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.079266", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007781", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.05939", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRSO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NMR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:AMPL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTX", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00696", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:EOT", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.000625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SLS", "relevance_score": "0.003453", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:TRX", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.198959", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC\u2122 Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022", "url": "https://www.globenewswire.com/news-release/2022/03/09/2399737/0/en/Design-Therapeutics-Announces-Preclinical-Data-Highlighting-Novel-GeneTAC-Therapy-for-the-Treatment-of-Fuchs-Endothelial-Corneal-Dystrophy-to-be-Presented-at-ARVO-2022.html", "time_published": "20220309T113000", "authors": ["Inc.", "Design Therapeutics"], "summary": "Treatment with GeneTAC\u2122 Small Molecules Reduced Nuclear Foci and Restored Normal Splicing In Vitro, Supporting Further Development Treatment with GeneTAC\u2122 Small Molecules Reduced Nuclear Foci and Restored Normal Splicing In Vitro, Supporting Further Development", "banner_image": "https://ml.globenewswire.com/Resource/Download/bbfe687d-5236-42ea-8012-8ab435c6914d?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.025373, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.227966", "ticker_sentiment_score": "0.025373", "ticker_sentiment_label": "Neutral"}]}, {"title": "Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC\u2122 Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022", "url": "https://www.benzinga.com/pressreleases/22/03/g26056631/design-therapeutics-announces-preclinical-data-highlighting-novel-genetac-therapy-for-the-treatmen", "time_published": "20220309T113000", "authors": [], "summary": "CARLSBAD, Calif., March  09, 2022   ( GLOBE NEWSWIRE )  -- Design Therapeutics, Inc.  ( NASDAQ:DSGN ) , a biotechnology company developing treatments for degenerative genetic disorders, today announced that preclinical data supporting the potential of the company's novel GeneTAC\u2122 small molecules to ", "banner_image": "https://ml.globenewswire.com/media/bbfe687d-5236-42ea-8012-8ab435c6914d/small/designtx-logo-colored-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.036066, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSGN", "relevance_score": "0.214652", "ticker_sentiment_score": "0.036066", "ticker_sentiment_label": "Neutral"}]}]}